Natural Compounds | sciencenewsnet.in

Breaking News

Additional comments on extracellular vesicles derived from mesenchymal stem cells mediate extracellular matrix remodeling in osteoarthritis

Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury

Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease

Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD

UF scientists study how to bring you ‘climate-smart coffee’

Moffitt Study Uncovers Key Immune Cells for Combating Aggressive Merkel Cell Carcinoma

Chula hosted “The Second Chulalongkorn University President’s Distinguished Speakers” a Special Lecture on “Revolutionizing the Future: An Exclusive Talk with “Andrew Ng” on Opportunities and Business Preparedness” by the World’s Influential AI Exper

Cleaning the window of opportunity: Towards a typology of sustainability entrepreneurs

Does information disclosure alleviate overcrowding? An empirical study based on large-scale COVID-19 nucleic acid test

Researchers develop state-of-the-art device to make artificial intelligence more energy efficient

27 Jul, 2024

Innovative Light-Driven Enzymatic Biosystem for the Synthesis of Natural Terpenoids

July 1, 2024 sarah JonasResearch Results

In a recent study, researchers from China have developed a light-driven in vitro enzymatic system to produce α-farnesene, a useful natural terpenoid, from methanol. By optimizing and coupling thirteen biocatalytic reactions, and using natural thylakoid membranes, they achieved a significant α-farnesene production using methanol and glycolaldehyde as source materials.

Sandalwood Oil By-product Prevents Prostate Cancer Development in Mice

February 13, 2024 sarah JonasResearch Results

Sandalwood oil has been used worldwide for centuries. Now, a study is the first to demonstrate in vivo the chemo-preventive properties of a by-product of the oil in a mouse model. Results show administering alpha-santalol reduced visible prostate tumors, protected the normal tissue, and delayed progression from a precancerous condition to a high-grade form of cancer. These findings are significant because mortality in prostate cancer patients is mainly attributable to advanced stages of the disease.